Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions. | Biomedicines | 2022 | 35327339 | PubTator, text mining | PubMed |
| Negative Regulation and Protective Function of Natural Killer Cells in HIV Infection: Two Sides of a Coin. | Front Immunol | 2022 | 35320945 | PubTator, text mining | PubMed |
| Non-GCB Diffuse Large B-Cell Lymphoma With an Atypical Disease Course: A Case Report and Clinical Exome Analysis. | World J Oncol | 2022 | 35317330 | PubTator, text mining | PubMed |
| Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma. | Front Cell Dev Biol | 2022 | 35309925 | PubTator, text mining | PubMed |
| In vitro assessment of skin sensitization, irritability and toxicity of bacteriocins and reuterin for possible topical applications. | Sci Rep | 2022 | 35301365 | PubTator, text mining | PubMed |
| Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. | Cancer Manag Res | 2022 | 35300059 | PubTator, text mining | PubMed |
| Cancer cell-intrinsic resistance to BiTE therapy is mediated by loss of CD58 costimulation and modulation of the extrinsic apoptotic pathway. | J Immunother Cancer | 2022 | 35296559 | PubTator, text mining | PubMed |
| The Modified THP-1 Activation Assay for the In Vitro Identification of Drug-Inducing Systemic Hypersensitivity. | Front Toxicol | 2022 | 35295210 | PubTator, text mining | PubMed |
| CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphoma. | J Pathol Clin Res | 2022 | 35289116 | PubTator, text mining | PubMed |
| Transposable Elements and Human Diseases: Mechanisms and Implication in the Response to Environmental Pollutants. | Int J Mol Sci | 2022 | 35269693 | PubTator, text mining | PubMed |
| The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. | Cancers (Basel) | 2022 | 35267668 | PubTator, text mining | PubMed |
| Mesenchymal stem cells and natural killer cells interaction mechanisms and potential clinical applications. | Stem Cell Res Ther | 2022 | 35255980 | PubTator, text mining | PubMed |
| Supported Lipid Bilayers and the Study of Two-Dimensional Binding Kinetics. | Front Mol Biosci | 2022 | 35252352 | PubTator, text mining | PubMed |
| Identification of Genetic Networks Reveals Complex Associations and Risk Trajectory Linking Mild Cognitive Impairment to Alzheimer's Disease. | Front Aging Neurosci | 2022 | 35250545 | PubTator, text mining | PubMed |
| A novel bi-alleleic DDX41 mutations in B-cell lymphoblastic leukemia: case report. | BMC Med Genomics | 2022 | 35246110 | PubTator, text mining | PubMed |
| Integrated Genomic and Transcriptomic Analyses of Diffuse Large B-Cell Lymphoma With Multiple Abnormal Immunologic Markers. | Front Oncol | 2022 | 35237512 | PubTator, text mining | PubMed |
| Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells. | J Oncol | 2022 | 35237321 | PubTator, text mining | PubMed |
| The mechanisms of mutual relationship between malignant hematologic cells and mesenchymal stem cells: Does it contradict the nursing role of mesenchymal stem cells? | Cell Commun Signal | 2022 | 35236376 | PubTator, text mining | PubMed |
| miR-152-3p impedes the malignant phenotypes of hepatocellular carcinoma by repressing roundabout guidance receptor 1. | Cell Mol Biol Lett | 2022 | 35236289 | PubTator, text mining | PubMed |
| Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies. | Cell Rep | 2022 | 35235790 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=33